BioXcel Therapeutics, Inc. ( BTAI) - Key Metrics
Stock symbol BTAI is outdated, potentially delisted? Maybe it is available on other exchange?
BTAI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.49 | -$0.20 | -$0.20 |
| 2026Q1 | $0.02 | -$1.04 | -$0.97 | -$0.97 |
| 2025Q4 | $0.02 | -$1.03 | -$1.16 | -$1.16 |
| 2025Q3 | $0.01 | -$2.18 | -$1.32 | -$1.32 |
| 2025Q2 | $0.02 | -$2.45 | -$1.60 | -$1.60 |
BTAI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.72 |
| 2026Q1 | 0% | -0.32 |
| 2025Q4 | 0% | -0.39 |
| 2025Q3 | 0% | -0.29 |
| 2025Q2 | 0% | -0.18 |
BTAI
Price: $0.07
52 week price:
Earnings Per Share: -4.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 510800
Market Capitalization: 2.3 million